CSI Market
Sign In | Register

Alzamend Neuro Inc (ALZN) Annual Income Statement

Annual · GAAP · USD millions
Access ALZN quarterly income statements →
Reviewing income statement figures over time helps illustrate how Alzamend Neuro Inc generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
2026 		(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Revenues
Total Revenue0.00
Costs & Expenses
Gross Profit0.00
Selling, Administration, Marketing5.14
Depreciation & Amortization0.11
Research and Development Expense3.63
Total operating costs including COS8.77
Operating income / -loss-8.77
Interest Expense0.01
Interest Income0.00
Net Interest (-)Expense / Income-0.01
Extinguishment of Debt0.00
Loss / -Gain on Investment0.00
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes-8.77
Income after income taxes0.00
Income / -loss from continuing operations8.80
Net income / -loss8.80
Income / -loss to shareholder-8.77
EBIT-8.77
EBITD-8.68
EBITDA-8.67
Earnings Per Share
Basic EPS (excl. extra items)-2.63
Basic Net EPS-2.63
Basic shares outstanding (Mill. of Units)3.34
Diluted Net EPS-2.63
Diluted average shares (Mill. of Units)3.34
4 historic quarters locked

Sign in to unlock the full Alzamend Neuro Inc income statement history.

Sign In Create Free Account

About Alzamend Neuro Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: July 22, 2026
  • Original filing: az72426110k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.